Why Health Canada’s Recent Announcement Could Be Bad News for Canopy Growth (TSX:WEED)

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) has long been the industry leader in Canada, but will more competition put that in jeopardy?

| More on:
Person Hands Opening Mailbox To Remove Newspaper

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

We could be seeing a lot more competition in the cannabis industry very soon.

Health Canada recently announced that it would be making it easier for companies to obtain cannabis licenses. Previously, applicants didn’t have to have their sites ready to go before submitting their applications, which has created a lot of back-and-forth that wasn’t necessary that the government felt resulted in a lot of inefficiencies and bottlenecks along the way.

With a supply shortage of cannabis in Canada, there’s definitely an incentive to expedite the process. By requiring applicants to have a site already built and in compliance with regulations right at the start, it will help streamline the process and ensure that time isn’t being wasted on applicants that still have a long ways to go.

More competition could be bad news for industry leaders

While a company like Canopy Growth Corp (TSX:WEED)(NYSE:CGC) might be enjoying its place atop the industry today, more competition will make it more difficult for the company to keeps its advantage and strong market share. With advertising in the industry being limited, there’s not much of an advantage Canopy Growth can have over its rivals, especially in Ontario, where restrictions around store ownership mean it will have limited say in the retail side of things.

And with an increase in competition, that will help drive down prices and give consumers more options to choose from. Both of those consequences will have a negative impact on Canopy Growth’s financials, which aren’t all that strong to begin with. While some of the more promising competitors have been acquired by Canopy Growth and other big cannabis companies, further acquisitions will require cash being spent or a company having to issue new shares, resulting in dilution for existing shareholders.

Industry leaders don’t want to see too much competition, as it will result in more effort being needed to win market share by driving costs and prices down as much as possible. Although Canopy Growth has managed to turn a profit in two of its past five quarters, operationally it has been nowhere near break even as it has been other income that has been able to land the company into the black.

Bottom line

For consumers, the news from Health Canada is a big win. By getting more growers and producers out there, it’ll help the industry meet demand and hopefully keep more customers from having to go to the black market. However, with the possibility for even more fragmentation in an industry that already has lot of small companies vying for market share, it’s going to make it more difficult for a single company to dominate the market.

The key will lie in acquisitions, and that’s where having a strong balance sheet and lots of cash on hand is going to be paramount to staying near the top of the industry. For Canopy Growth, that could be a problem, especially with the company focusing on the U.S. market lately.

 

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »